Publications

5674 Results

Circulating tumor cell (CTC) counts are prognostic of overall survival in SWOG S0421: docetaxel with or without atrasentan for metastatic castration resistant prostate cancer

Authors
A Goldkorn;B Ely;D Quinn;C Tangen;L Fink;T Xu;P Twardowski;P Van Veldhuizen;N Agarwal;M Carducci;JP Monk;RH Datar;M Garzotto;PC Mack;PN Lara;CS Higano;M Hussain;I Thompson;R Cote;N Vogelzang
Journal / Conference
Journal of Clinical Oncology 32(11):1136-1142;
Year
2014
Research Committee(s)
Genitourinary
PMID
PMID24616308
PMC
PMC3970171
Study Number(s)
S0421

Southwest Oncology Group S0008: A Phase III trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine DTIC, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma-An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

Authors
LE Flaherty;M Othus;MB Atkins;RJ Tuthill;JA Thompson;JT Vetto;FG Haluska;AS Pappo;JA Sosman;BG Redman;J Moon;A Ribas;JM Kirkwood;VK Sondak
Journal / Conference
Journal of Clinical Oncology 32(33):3771-3778;
Year
2014
Research Committee(s)
Melanoma
PMID
PMID25332243
PMC
PMC4226807
Study Number(s)
S0008

Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival

Authors
WE Carson;JM Unger;J Sosman;LE Flaherty;RJ Tuthill;M Park;MJ Porter;PI Terasaki;JA Thompson;RA Kempf;M Othus;A Ribas;VK Sondak
Journal / Conference
Cancer Immunology Research 2(10):981-987;
Year
2014
Research Committee(s)
Melanoma
PMID
PMID24994597
PMC
PMC4185232
Study Number(s)
SWOG-9035

Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202

Authors
MR Smith;S Halabi;CJ Ryan;A Hussain;N Vogelzang;W Stadler;R Hauke;JP Monk;P Saylor;N Bhoopalam;F Saad;B Sanford;WK Kelly;M Morris;EJ Small
Journal / Conference
Journal of Clinical Oncology 32(11):1143-1150;
Year
2014
Research Committee(s)
Genitourinary
PMID
PMID24590644
PMC
PMC3970172
Study Number(s)
CTSU/C90202

Is there a role for body mass index in assessment of prostate cancer risk on biopsy?

Authors
Y Liang;NS Ketchum;P Goodman;E Klein;IM Thompson
Journal / Conference
Journal of Urology 192(4):1094-1099;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID24747090
PMC
PMC4194238
Study Number(s)
S0000

Pre-operative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual particpant data. [P. Bunn and K. Pisters collaborators]

Authors
S Burdett;NSCLC Meta-analysis Collab Grp
Journal / Conference
Lancet 383(9928):1561-1571;
Year
2014
Research Committee(s)
Lung
PMID
PMID24576776
PMC
PMC4022989
Study Number(s)
SWOG-9015, S9900

Randomized phase II study of docetaxel plus vandetanib vs. docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904

Authors
R Coleman;J Moon;AK Sood;W Hu;JE Delmore;AJ Bonebrake;G Anderson;S Chambers;M Markman
Journal / Conference
European Journal of Cancer 50(9):1638-1648;
Year
2014
Research Committee(s)
Gynecologic
PMID
PMID24709487
PMC
PMC4098779
Study Number(s)
S0904

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG protocol S0433

Authors
J Friedberg;J Unger;WR Burack;AJ Gopal;RN Raju;A Nademanee;M Kaminski;M Leblanc;H Li;OW Press;TP Miller;RI Fisher
Journal / Conference
British Journal of Haematology 166(3):382-389;
Year
2014
Research Committee(s)
Lymphoma
PMID
PMID24749780
PMC
PMC4107050
Study Number(s)
S0433

Enhancing nurse contributions to SWOG clinical trials

Authors
L Hansen;C Moinpour;R Ermete
Journal / Conference
Seminars in Nursing Oncology 30(1):26-31;
Year
2014
Research Committee(s)
Brain, Breast, Cancer Control, Cancer Survivorship, Gastrointestinal, Genitourinary, Gynecologic, Lung, and Symptom Management and Survivorship
PMID
PMID24559777
PMC
PMC3961058
Study Number(s)
S0205, S0229, S0316, S0715, SWOG-8313 (EST 5186), SWOG-8807, SWOG-8894 (INT-0105) (EST-2889), SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021), SWOG-9045, SWOG-9217, SWOG-9248, SWOG-9324, SWOG-9418, SWOG-9509, S9832, S9916, S9917

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

Authors
B Gurel;MS Lucia;IM Thompson;P Goodman;C Tangen;A Kristal;H Parnes;SM Lippman;S Sutcliffe;S Pescoe;C Drake;W Nelson;A DeMarzo;E Platz
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention 23(5):847-856;
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID24748218
PMC
PMC4012292
Study Number(s)
SWOG-9217